Skip to main content
Caplight Logo









Juno Bio

Juno Bio

Private
LondonHealthcare & Life Scienceshttps://www.juno.bio/

Last Round

Seed

Jul 16, 2026

Total Funding Raised

$8.4M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Juno Bio is a biotechnology company that provides at-home vaginal microbiome testing kits and research services.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, D2C Brands, Precision Medicine, Subscription Commerce

Business Model

B2C

Customer Profile

Hardware Sales, Services & Consulting, Hardware + Subscription

AI Layer

Application

Keywords

vaginal microbiome testFemTechat-home test kitmicrobiome testingvaginal healthwomen's healthnext-generation sequencingNGSbacterial vaginosisBV testdirect-to-consumerDTCinfertility insightsvaginal coachingwomen's health researchprecision medicinebioinformatics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Juno Bio Comparables

Compare Juno Bio with similar companies based on industry and business-model similarity.

Juno Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Evvy
91%
Psomagen, Inc.
81%
Daye
76%

Juno Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 16, 2026
SeedAug 1, 2023
AcceleratorApr 23, 2019

Key People

Founding team and executive leadership

Leighton Turner

Founder & CTO

Founding Team

Hana Janebdar

Cofounder, CEO

Founding Team

Juno Bio Investors

Notable investors and investment history

Juno Bio investors
InvestorRounds
Acequia CapitalSeed
Ada VenturesSeed
Alma AngelsSeed
ArtesianSeed
SpeedinvestSeed
Crista Galli VenturesSeed
Entrepreneurs FirstSeed, Accelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased to 8, 8x the trailing average.

  • Jul 16, 2026

    $3.8M round led by Ada Ventures

Juno Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Juno Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Juno Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range5
Year Founded2018
Last FundingJul 16, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?